BioSpace News Archive

BioCapital

Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC

Ascentage Pharma (6855.HK) announced today that it has released the latest clinical data of its dual Bcl-2/Bcl-xL inhibitor, APG-1252 (pelcitoclax), combined with osimertinib for the treatment of patients with EGFR-mutant non-small cell lung cancer (NSCLC) in a Mini Oral at the 2023 European Society of Medical Oncology (ESMO) Congress.

October 23, 2023
·
7 min read
Genetown

Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington’s Disease

Skyhawk Therapeutics today announced the Australian Human Research Ethic Committee (HREC) approval by Australian regulators for a clinical trial for Skyhawk’s SKY-0515 small molecule candidate targeting Huntington’s disease (HD).

October 23, 2023
·
3 min read
Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, has unveiled what it believes to be an entirely new cancer detection method at ESMO 2023¹, the annual congress of the European Society for Medical Oncology.

October 23, 2023
·
7 min read
Business

Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors

Neuros Medical, Inc. today announced that David Veino has been appointed President and Chief Executive Officer.

October 23, 2023
·
4 min read